These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2353352)

  • 21. Association of lipoprotein cholesterol and triglycerides with the severity of coronary artery disease in men and women.
    Korhonen T; Savolainen MJ; Koistinen MJ; Ikäheimo M; Linnaluoto MK; Kervinen K; Kesäniemi YA
    Atherosclerosis; 1996 Dec; 127(2):213-20. PubMed ID: 9125311
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Frequency and role of apo E phenotype in familial hypercholesterolemia and non-familial hyperlipidemia in the Japanese.
    Kitahara M; Shinomiya M; Shirai K; Saito Y; Yoshida S
    Atherosclerosis; 1990 Jun; 82(3):197-204. PubMed ID: 2375785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apolipoprotein E polymorphism and the distribution profile of very low density lipoproteins; an influence of the E4 allele on large (Sf > 60) particles.
    Bioletto S; Fontana P; Darioli R; James RW
    Atherosclerosis; 1998 May; 138(1):207-15. PubMed ID: 9678786
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Apolipoprotein E and its alleles in healthy subjects and in atherosclerosis].
    Couderc R; Bailleul S
    Ann Biol Clin (Paris); 1998; 56(6):651-9. PubMed ID: 9853024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apolipoprotein E polymorphism and the characteristics of diseased vessels in male Chinese patients with angiographic coronary artery disease: a case-case study.
    Li SS; Yang J; Li LS; Wang HC
    Clin Cardiol; 2010 Jun; 33(6):E30-4. PubMed ID: 20552590
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between obesity and serum lipoproteins in children with different apolipoprotein E phenotypes: the Bogalusa Heart Study.
    Srinivasan SR; Ehnholm C; Wattigney WA; Berenson GS
    Metabolism; 1994 Apr; 43(4):470-5. PubMed ID: 8159106
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The relevance of a protein-enriched low density lipoprotein as a risk for coronary heart disease in relation to other known risk factors.
    Swinkels DW; Demacker PN; Hendriks JC; Brenninkmeijer BJ; Stuyt PM
    Atherosclerosis; 1989 May; 77(1):59-67. PubMed ID: 2719763
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of apolipoprotein E genotype on the reliability of the Friedewald formula in the estimation of low-density lipoprotein cholesterol concentrations.
    Tremblay AJ; Bergeron J; Gagné JM; Gagné C; Couture P
    Metabolism; 2005 Aug; 54(8):1014-9. PubMed ID: 16092050
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
    Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
    Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apolipoprotein E polymorphism modulates the association between obesity and dyslipidemias during young adulthood: The Bogalusa Heart Study.
    Srinivasan SR; Ehnholm C; Elkasabany A; Berenson GS
    Metabolism; 2001 Jun; 50(6):696-702. PubMed ID: 11398147
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of apolipoprotein E polymorphism and apolipoprotein A-1 gene promoter polymorphism on lipid parameters and premature coronary artery disease.
    Petrovic D; Zorc M; Peterlin B
    Folia Biol (Praha); 2000; 46(5):181-5. PubMed ID: 11055796
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apolipoprotein E phenotype affects the malondialdehyde-modified LDL concentration and forearm endothelial function in postmenopausal women.
    Tsuda M; Sanada M; Higashi Y; Hara Y; Kodama I; Chayama K; Yoshizumi M; Ohama K
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):619-25. PubMed ID: 15521966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of apolipoprotein E polymorphism on plasma lipid and apolipoprotein levels, and clinical characteristics of type III hyperlipoproteinemia due to apolipoprotein E phenotype E2/2 in Japan.
    Kobori S; Nakamura N; Uzawa H; Shichiri M
    Atherosclerosis; 1988 Jan; 69(1):81-8. PubMed ID: 3355609
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lipoprotein and apolipoprotein levels in angiographically defined coronary atherosclerosis.
    Schmidt SB; Wasserman AG; Muesing RA; Schlesselman SE; Larosa JC; Ross AM
    Am J Cardiol; 1985 Jun; 55(13 Pt 1):1459-62. PubMed ID: 3923814
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apolipoprotein E polymorphism and coronary artery disease.
    Menzel HJ; Kladetzky RG; Assmann G
    Arteriosclerosis; 1983; 3(4):310-5. PubMed ID: 6882285
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apolipoprotein E polymorphism is associated with both carotid and coronary atherosclerosis in patients with coronary artery disease.
    Granér M; Kahri J; Varpula M; Salonen RM; Nyyssönen K; Jauhiainen M; Nieminen MS; Syvänne M; Taskinen MR
    Nutr Metab Cardiovasc Dis; 2008 May; 18(4):271-7. PubMed ID: 17462871
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apolipoprotein E polymorphism and carotid atherosclerosis in patients with coronary disease.
    Fernández-Miranda C; Aranda JL; Martín MA; Arenas J; Núñez V; Gómez de la Cámara A
    Int J Cardiol; 2004 Apr; 94(2-3):209-12. PubMed ID: 15093983
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relevance of apolipoprotein E4 for the lipid profile of Brazilian patients with coronary artery disease.
    Souza DR; Nakachima L; Biagioni RB; Nakazone MA; Pinhel MA; Trindade DM; Mafra VT; Tácito LH; Martin JF; Pinheiro Júnior S; Brandão AC
    Braz J Med Biol Res; 2007 Feb; 40(2):189-97. PubMed ID: 17273655
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apolipoprotein E genotype and cardiovascular disease in the Framingham Heart Study.
    Lahoz C; Schaefer EJ; Cupples LA; Wilson PW; Levy D; Osgood D; Parpos S; Pedro-Botet J; Daly JA; Ordovas JM
    Atherosclerosis; 2001 Feb; 154(3):529-37. PubMed ID: 11257253
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Women have a larger and less atherogenic low density lipoprotein particle size than men.
    Nikkilä M; Pitkäjärvi T; Koivula T; Solakivi T; Lehtimäki T; Laippala P; Jokela H; Lehtomäki E; Seppä K; Sillanaukee P
    Atherosclerosis; 1996 Jan; 119(2):181-90. PubMed ID: 8808495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.